Építés alatt – nem éles oldal
Belépés

Áttétes emlőrák trials, also abroad

609 open Áttétes emlőrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Kína224
Egyesült Államok222
Franciaország82
Spanyolország73
Olaszország70
All other countries

The same trial often runs in several countries

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer has 5 sites in Thaiföld and runs in 29 countries. If a site near you is full, another one may still take people.

See Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer in all 29 countries
Építés alatt, nem éles – Áttétes emlőrák: vizsgálatok itt: Thaiföld – Frontlight Research